🚨🚨Brain RT can affect fine motor skills (FMS) ✍️📱 & 🖐️👁️coordination. But can we PREVENT it? YES! ➡️Check out our lab’s latest from 🔥Dr. Mike Connor: 1st NTCP study of FMS using multivariate approach & prospective data #btsm#survivorship#functionalpreservation 1/🧵
From #RedJournal: 1st NTCP analyses of fine motor skills decline after brain RT-using data from prospective trial. Dose to supratentorial motor ROIs (WM, cortex) predicted decline on dominant hand FMS at 6mo. @JHGLab@UCSDRadMed@MSalans#btsm#drconnorbit.ly/hatglu2
Congrats to Moores Member Catheryn Yashar, MD, for receiving the ACRO Gold Medal! Honored by the ACRO Board of Chancellors, she’s recognized for her outstanding service and exceptional contributions to radiation oncology. Learn more: bit.ly/44RoHG4
🚨TOROEDO trial - superbly executed with uniform RT plan QA/no crossover.
No difference in either endpoints.
What’s next? Refine the strategy. Technology is a means to an end. Reduce volume and dose (gross/elective) with biology based therapy selection.
@ASTRO_org#astro25
Groundbreaking presentation from @JHGLab - NIH-funded trial of Brain connectome-sparing SRS w/ AI-supported planning approaches is:
-feasible
-assoc with good tumor control and stable/improved cognitive function
-time for a randomized trial!
@NeuroOnc
Congratulation to all awardees🎉🥳, especially our own Helen Shih who we are so lucky to have amongst us. Dr Shih's passion for mentoring and excellence is absolutely amazing, and she does it all with the highest level of diligence & integrity. An inspiration to all of us‼️ 👏👏👏
@MGHCancerCenter @MGH_WiO@BrighamRadOnc@DKirschMDPhD@AmyWisdom8@RachelJimenezMD@AE_MarciscanoMD@EmilyLebow
NIH funding generated $2.46 for every $1 funded in 2023.
Important info for scientific advocacy in the years ahead- science is a quantifiable investment, not just a cost.
H/t to @NicoleCRust for sharing!
fiercebiotech.com/research/r…
Medullo CSI week 7/7
Who pionered CSI?
Because of freq seeding to brain/cord,
Edith Paterson developed & advocated for CSI
doi.org/10.3109/000169253091…
Totally agree, How amazing!! Two phenomenal leaders who inspire everyone around them! Absolute legends. Look forward to celebrating them @NeuroOnc soon! #btsm Congratulations! @MGHCancerCenter @TheLizArmy
Absolutely brilliant news! Congrats @TheLizArmy!!! Thank you so much for all that you do to amplify the patient voice. Great job @NeuroOnc for recognizing a living legend! #BTSM
Excited to share about NRG GI-011 (aka LAP100) – anticipated opening in mid/early 2025.
In this Phase III RCT, we are assessing the benefit of dose-escalated radiotherapy in patients with locally advanced unresectable pancreas cancer. 🧵1/11
So proud of MS3 Hieu Nguyen for his stellar presentation of innovative work exploring hippocampal subregions & influence on memory @UCSDRadMed #btsm#ASTRO24 @JYangMDPhD
What an honor to be among this 2024 class of fellows, including the amazing Jyoti Mayadev and celebrating with the one and only @SameerKeoleMD@ASTRO_org@UCSDRadMed
Congratulations to @andyzwang, new #AAASFellow@aaas — our family is so proud of you & your contributions to medicine and science.
May you continue to think outside of the box, create & innovate to push the boundaries in cancer & disease.
@UTSW_RadOnc@utswcancer@UTSWMedCenter